Select Publications & Resources

The Globe and Mail. Inez Jabalpurwala, the global director of the Viral Neuro Exploration (VINEx) initiative, makes the case that COVID-19 research needs to include survivors of the pandemic that have a reduced quality of life and potentially lasting neurological impacts -- and that Canada can lead the way. 

Forbes. As the founding CEO of Brain Canada and now the global director of the Viral Neuro Exploration (known as “VINEx”), a social impact venture that was initiated by Rocket Science Health, a private medical device company, Jabalpurwala has been a catalyst, rallying and closely collaborating with a community of scientists from different fields and disciplines. 

VINEx to Provide Catalytic Leadership for Research into a Vital Area in the Fight Against SARS-CoV-2 and other Viruses which may have Lasting Effects on the Brain.

Rocket Science Health today announced that Robyn S. Klein, MD, PhD, has joined the Science Advisory Council (SAC) for VINEx.

The Adam Stirling Show (CFAX 1070). There are many unknowns about Covid-19 and the effect it has on the brains of patients is one of them. Inez Jabalpurwala, Global Director for VINEx, spoke with Adam about a multi-disciplinary exploration of the virus-brain connection. 

The Globe and Mail. Brought together as part of a new initiative called VINEx, created by Rocket Science Health, a Victoria-based medical devices company, the group is aiming to lead the charge in understanding how viruses invade the brain – an area of study that has received relatively little attention.

Creating a platform of exchange and communication. If you are interested in becoming part of this community, please register at the Center for Global Health, Department of Neurology, Technical University of Munich, Germany, by sending an email to: covid19.neuro@med.tum.de.

de Erausquin, GA, Snyder, H, Carrillo, M, et al. The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning. Alzheimer's Dement. 2021; 1– 9.

Holmes, Emily A et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet Psychiatry, Volume 7, Issue 6, 547 – 560

Helbok, R., Chou, S., Beghi, E., Mainali, S., Frontera, J., Robertson, C., Fink, E., Schober, M., Moro, E., McNett, M. and Bassetti, C., 2021. Neurocovid: It's Time To Join Forces Globally. The Lancet Neurology.

Nath, Avindra. Neurologic complications of coronavirus infections. Neurology. May 2020, 94 (19) 809-810; DOI: 10.1212/WNL.0000000000009455

Solomon, T. Neurological infection with SARS-CoV-2 — the story so far. Nat Rev Neurol 17, 65–66 (2021). https://doi.org/10.1038/s41582-020-00453-w

Taquet, M., Luciano, S., Geddes, J. and Harrison, P., 2021. Bidirectional Associations Between COVID-19 And Psychiatric Disorder: Retrospective Cohort Studies Of 62 354 COVID-19 Cases In The USA. Lancet Psychiatry.

Natoli, S., Oliveira, V., Calabresi, P., Maia, L.F. and Pisani, A. (2020), Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models. Eur J Neurol. doi: 10.1111/ene.14277

Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi:10.1001/jamaneurol.2020.1127

Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019:  A Review. JAMA Neurol. Published online May 29, 2020. doi:10.1001/jamaneurol.2020.2065

Butowt R, Bilinska K. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection. ACS Chem Neurosci. 2020;11(9):1200-1203. doi:10.1021/acschemneuro.0c00172

Chen X, Laurent S, Onur OA, et al. A systematic review of neurological symptoms and complications of COVID-19 [published online ahead of print, 2020 Jul 20]. J Neurol. 2020;1-11. doi:10.1007/s00415-020-10067-3

De Felice, Fernanda G. et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System. Trends in Neurosciences, Volume 43, Issue 6, 355 – 357

Desforges M, Le Coupanec A, Dubeau P, et al. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System. Viruses. 2019;12(1):14. Published 2019 Dec 20. doi:10.3390/v12010014

Bohmwald K, Gálvez NMS, Ríos M and Kalergis AM (2018) Neurologic Alterations Due to Respiratory Virus Infections. Front. Cell. Neurosci. 12:386. doi: 10.3389/fncel.2018.00386

Arbour N, Day R, Newcombe J, Talbot PJ. Neuroinvasion by Human Respiratory Coronaviruses. Journal of Virology. Oct 2000, 74 (19) 8913-8921; DOI: 10.1128/JVI.74.19.8913-8921.2000

Huang, C. et al., 2021. 6-Month Consequences Of COVID-19 In Patients Discharged From Hospital: A Cohort Study. The Lancet.

Nehme M, Braillard O, Alcoba G, Perone S, Courvoisier D, Chappuis F, Guessous I. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Annals of Internal Medicine. December 8, 2020.

February 10, 2021 - Newsweek

February 1, 2021 - France24

January 23, 2021 - CBC Marketplace

Related Article: 60% of COVID-19 long-haulers say government is 'absolutely ignoring them,' Marketplace questionnaire finds. CBC

January 21, 2021 - The Guardian

January 21, 2021 -  New York Times

January 21, 2021 - Scientific American.

January 20, 2021 - The Scientist

January 14, 2021 - NIH Director's Blog

December 4, 2020 - New York Times

November 9, 2020 - Reuters

October 11, 2020 - New York Times

September 28, 2020 - Yale News

September 15, 2020 - Nature

November 1, 2020 - Monitor on Psychology

September 9, 2020 - New York Times

August 12, 2020 - Stat

July 8, 2020 - The Conversation

June 2020 - The Atlantic

May 28, 2020 - Psychiatric Times

A grassroots organization to connect and mobilize COVID-19 survivors to engage in research studies to further our understanding of long-term effects of the disease.